IL6 and breast cancer: So, the blockade of IL-6 inflammatory signaling cascade has been investigated as a potential therapeutic strategy to suppress hepcidin in breast cancer and for anaemic cancer patients (Jiang et al., 2011; Guo et al., 2015).